19-50402473-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002691.4(POLD1):ā€‹c.778A>Gā€‹(p.Ile260Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000495 in 1,612,604 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I260M) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.0027 ( 0 hom., cov: 33)
Exomes š‘“: 0.00026 ( 2 hom. )

Consequence

POLD1
NM_002691.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:14

Conservation

PhyloP100: 1.93
Variant links:
Genes affected
POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008218169).
BP6
Variant 19-50402473-A-G is Benign according to our data. Variant chr19-50402473-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 221152.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1, Benign=8}. Variant chr19-50402473-A-G is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 415 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
POLD1NM_002691.4 linkuse as main transcriptc.778A>G p.Ile260Val missense_variant 7/27 ENST00000440232.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
POLD1ENST00000440232.7 linkuse as main transcriptc.778A>G p.Ile260Val missense_variant 7/271 NM_002691.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00271
AC:
412
AN:
152222
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00936
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.000692
AC:
170
AN:
245820
Hom.:
0
AF XY:
0.000473
AC XY:
63
AN XY:
133330
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.000352
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000263
AC:
384
AN:
1460264
Hom.:
2
Cov.:
34
AF XY:
0.000237
AC XY:
172
AN XY:
726316
show subpopulations
Gnomad4 AFR exome
AF:
0.00963
Gnomad4 AMR exome
AF:
0.000495
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000900
Gnomad4 OTH exome
AF:
0.000481
GnomAD4 genome
AF:
0.00272
AC:
415
AN:
152340
Hom.:
0
Cov.:
33
AF XY:
0.00255
AC XY:
190
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00940
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.000468
Hom.:
0
Bravo
AF:
0.00304
ESP6500AA
AF:
0.00909
AC:
40
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000799
AC:
97
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:14
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:3
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoNov 14, 2017- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 18, 2019- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 04, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalAug 15, 2023- -
not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 12, 2021- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 22, 2021- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2022POLD1: BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hereditary cancer-predisposing syndrome Benign:3
Benign, criteria provided, single submittercurationSema4, Sema4Mar 01, 2020- -
Likely benign, no assertion criteria providedclinical testingTrue Health DiagnosticsOct 10, 2017- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 05, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Colorectal cancer, susceptibility to, 10 Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -
POLD1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 01, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Colorectal cancer, susceptibility to, 10;C3715192:Mandibular hypoplasia-deafness-progeroid syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.12
T;.;.;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.077
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.97
.;.;D;D
MetaRNN
Benign
0.0082
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.21
N;.;.;N
MutationTaster
Benign
1.0
D
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.10
N;.;.;.
REVEL
Benign
0.054
Sift
Benign
0.46
T;.;.;.
Sift4G
Benign
0.58
T;T;T;T
Polyphen
0.036
B;.;.;B
Vest4
0.13
MVP
0.50
MPC
0.16
ClinPred
0.011
T
GERP RS
4.2
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.7
Varity_R
0.052
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8105725; hg19: chr19-50905730; API